PRADAXA 110MG 30 CAPSULES

PRADAXA 110MG 30 CAPSULES
PRADAXA 110 MG 30 CAPSULES
Pradaxa 110 Mg - 30 Caps
Primary prevention of venous thromboembolic events in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery.
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischemic attack
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults
PRADAXA 110 MG 30 CAPSULES
Pradaxa (dabigatran) blocks the activity of certain clotting substances in the blood. Pradaxa is used to reduce the risk of stroke and blood clots in people who have a medical condition called atrial fibrillation. Pradaxa is also used to treat blood clots in the veins of your legs (deep vein thrombosis, or DVT) or lungs (pulmonary embolism, or PE) and reduce the risk of them occurring again.
PRADAXA 110 MG CAP 30 S
TRADE NAMEPradaxa 110Mg Capsules SCIENTIFIC NAMEDabigatran Etexilate (As Mesilate) PRODUCT TYPEHuman DRUG TYPENCE PHARMACEUTICAL FORMCapsule ADMINISTRATION ROUTEOral PACKAGE TYPESBlister LEGAL STATUSPrescription STORAGE CONDITIONSstore below 30°c COMPANYBOEHRINGER INGELHEIM REGISTER YEAR2009
dabigatran
For prevention and treatment of blood clotting.
Product Description
Prevention of stroke and systemic embolism in Non valvular atrial fibrilation patients
Oral administration Capsules taken  2 tablet once daily  (or) one Tablet  Twice Daily  According to the Indication  
Anti-Coagulation 
 
وصف المنتج
براداكسا
كبسولات للبلع عن طريق الفم